The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date

2 trials

Conditions

Rheumatoid arthritis Musculoskeletal DiseasesThe Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date Other

Phase 1

Deferred registration: Fortrea code 780279

Active, not recruitingISRCTN48262326

Sanofi (France)The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date Other

Start: 2026-08-28Target: 16Updated: 2026-07-13

Phase 2

Repair effects of leramistat in participants with rheumatoid arthritis

RecruitingISRCTN16456769

Istesso TherapeuticsRheumatoid arthritis Musculoskeletal Diseases

Start: 2026-04-20Target: 18Updated: 2026-07-13

The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date

Sponsors

Conditions

Phase 1

Phase 2